|
Sign In to gain access to subscriptions and/or personal tools.
|
The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice
J B Boringa
Department of Neurology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands, Department of Neurology, Ziekenhuis Eemland 3800 BM Amersfoort, The Netherlands
R HC Lazeron
Department of Diagnostic Radiology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
I EW Reuling
Department of Medical Psychology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
H J Adèr
Department of Clinical Epidemiology and Biostatistics, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
L EMA Pfennings
Department of Medical Psychology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
J Lindeboom
Department of Medical Psychology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
L MJ de Sonneville
Department of Neurology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
N F Kalkers
Department of Neurology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
C H Polman
Department of Neurology, Academisch Ziekenhuis Vrije Universiteit 1007 MB Amsterdam, The Netherlands
The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) is a sensitive measure of cognitive impairment in multiple sclerosis (MS) patients. It consists of the Selective Reminding Test, the 10/36 Spatial Recall Test, the Symbol Digit Modalities Test, the Paced Auditory Serial Addition Test and the Word List Generation Test. We administered one of two parallel versions of the test battery to 140 healthy subjects to produce normative values for both versions. As expected, test scores were influenced by certain variables like age, gender and education. Although constructed as two equivalent versions, for some tests the two versions showed significant differences in test scores, which could not be explained by differences in these variables.
Key Words: neuropsychological testing • Brief Repeatable Battery • normative values • multiple sclerosis
Multiple Sclerosis, Vol. 7, No. 4,
263-267 (2001)
DOI: 10.1177/135245850100700409
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L Strober, J Englert, F Munschauer, B Weinstock-Guttman, S Rao, and R. Benedict
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
Multiple Sclerosis,
September 1, 2009;
15(9):
1077 - 1084.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S Cader, J Palace, and P. Matthews
Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis
J Psychopharmacol,
August 1, 2009;
23(6):
686 - 696.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Koutsis, M Panas, E Giogkaraki, G Karadima, C Sfagos, and D Vassilopoulos
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis
Multiple Sclerosis,
February 1, 2009;
15(2):
174 - 179.
[Abstract]
[PDF]
|
|
|
|
|
|
|
X Lin, C R Tench, P S Morgan, and C S Constantinescu
Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
April 1, 2008;
79(4):
437 - 441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Woolmore, M. Stone, S. Holley, P. Jenkinson, A. Ike, P. Jones, A. Fryer, R. Strange, R. Stephens, D. Langdon, et al.
Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis
Multiple Sclerosis,
March 1, 2008;
14(2):
177 - 182.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, M. L. Bartolozzi, M. L. Stromillo, L. Guidi, G. Siracusa, S. Sorbi, et al.
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Arch Neurol,
August 1, 2007;
64(8):
1157 - 1161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lovera, B. Bagert, K. Smoot, C.D. Morris, R. Frank, K. Bogardus, K. Wild, B. Oken, R. Whitham, and D. Bourdette
Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial
Multiple Sclerosis,
April 1, 2007;
13(3):
376 - 385.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Scherer, I.K. Penner, A. Rohr, H. Boldt, I. Ringel, H. Wilke-Burger, E. Burger-Deinerth, K. Isakowitsch, M. Zimmermann, S. Zahrnt, et al.
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Multiple Sclerosis,
April 1, 2007;
13(3):
402 - 411.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Koutsis, M. Panas, E. Giogkaraki, C. Potagas, G. Karadima, C. Sfagos, and D. Vassilopoulos
APOE {varepsilon}4 is associated with impaired verbal learning in patients with MS
Neurology,
February 20, 2007;
68(8):
546 - 549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M P Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, M F De Caro, F Patti, R Vecchio, S Sorbi, and M Trojano
The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population
Multiple Sclerosis,
November 1, 2006;
12(6):
787 - 793.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F A H van der Linden, J J Kragt, J C Hobart, M Klein, A J Thompson, H M van der Ploeg, C H Polman, and B M J Uitdehaag
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life
J. Neurol. Neurosurg. Psychiatry,
October 1, 2006;
77(10):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J N. Zwemmer, J Berkhof, J A Castelijns, F Barkhof, C H Polman, and B M. Uitdehaag
Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics
Multiple Sclerosis,
September 1, 2006;
12(5):
565 - 572.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet
How to detect cognitive dysfunction at early stages of multiple sclerosis?
Multiple Sclerosis,
August 1, 2006;
12(4):
445 - 452.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J Sepulcre, S Vanotti, R Hernandez, G Sandoval, F Caceres, O Garcea, and P Villoslada
Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test
Multiple Sclerosis,
April 1, 2006;
12(2):
187 - 195.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al.
A longitudinal study of cognition in primary progressive multiple sclerosis
Brain,
December 1, 2005;
128(12):
2891 - 2898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R H. Lazeron, J B Boringa, M Schouten, B M. Uitdehaag, E Bergers, J Lindeboom, M J Eikelenboom, P H Scheltens, F Barkhof, and C H Polman
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis
Multiple Sclerosis,
October 1, 2005;
11(5):
524 - 531.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al.
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
April 1, 2005;
76(4):
519 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Krupp, C. Christodoulou, P. Melville, W. F. Scherl, W. S. MacAllister, and L. E. Elkins
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
Neurology,
November 9, 2004;
63(9):
1579 - 1585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Oral Presentations
Multiple Sclerosis,
September 1, 2004;
10(5_suppl):
S97 - S152.
[PDF]
|
|
|
|
|
|
|
M. P. Amato, M. L. Bartolozzi, V. Zipoli, E. Portaccio, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and N. De Stefano
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
Neurology,
July 13, 2004;
63(1):
89 - 93.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Christodoulou, L. B. Krupp, Z. Liang, W. Huang, P. Melville, C. Roque, W. F. Scherl, T. Morgan, W. S. MacAllister, L. Li, et al.
Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients
Neurology,
June 10, 2003;
60(11):
1793 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Achiron and Y Barak
Cognitive impairment in probable multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
April 1, 2003;
74(4):
443 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R L Aupperle, W W Beatty, F deNAP Shelton, and S T Gontkovsky
Three screening batteries to detect cognitive impairment in multiple sclerosis
Multiple Sclerosis,
October 1, 2002;
8(5):
382 - 389.
[Abstract]
[PDF]
|
|
|
|
|
